Envoy Medical, Inc.

Envoy Medical, Inc., trading under the ticker COCH, is a medical device company focused on fully implanted hearing technology, operating in the healthcare and medical devices sector. The company went public through a SPAC transaction via Anzu Special Acquisition Corp I, sponsored by Anzu Partners, with the SPAC having completed its IPO in 2021. The August 2021 Form 10-Q filing, accession number 0001104659-21-107102, reflects the company's financial reporting obligations during its transition to public-company status following the SPAC merger process. Envoy Medical's flagship product, the Esteem fully implanted hearing system, positions the company within the competitive hearing health device market. For full filing history, deal timelines, and analytical data on COCH and hundreds of other SPAC transactions, sign up for complete access at SpacDesk.